Sustainability Report

Overview

The report presents pharma&'s consolidated 2025 sustainability performance across environmental, social and governance topics. The company reports a double materiality assessment, participation in the UN Global Compact and a Communication on Progress. Total energy consumption fell to 12,801 MWh from 17,360 MWh in 2024, while gross Scope 1, location-based Scope 2 and Scope 3 emissions were 1,613, 771 and 63,729 tCO2e, respectively. It reports 347 employees at year-end and continued a US Patient Assistance Program.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services